Timely development of vaccines against SARS-CoV-2.
作者信息
Lu Shan
机构信息
Laboratory of Nucleic Acid Vaccines, Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA.
出版信息
Emerg Microbes Infect. 2020 Mar 8;9(1):542-544. doi: 10.1080/22221751.2020.1737580. eCollection 2020.
Abstract
摘要
相似文献
1
Timely development of vaccines against SARS-CoV-2.针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的疫苗的及时研发。
Emerg Microbes Infect. 2020 Mar 8;9(1):542-544. doi: 10.1080/22221751.2020.1737580. eCollection 2020.
2
Progress and Concept for COVID-19 Vaccine Development.新型冠状病毒肺炎疫苗研发进展与理念
Biotechnol J. 2020 Jun;15(6):e2000147. doi: 10.1002/biot.202000147. Epub 2020 May 7.
3
Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines: Setting Expectations Appropriately.严重急性呼吸综合征冠状病毒2疫苗：合理设定预期
Pediatr Infect Dis J. 2020 Jul;39(7):e123-e124. doi: 10.1097/INF.0000000000002741.
4
Next-generation vaccine platforms for COVID-19.用于新型冠状病毒肺炎的下一代疫苗平台
Nat Mater. 2020 Aug;19(8):810-812. doi: 10.1038/s41563-020-0746-0.
5
Coronavirus reinfections: three questions scientists are asking.新冠病毒再次感染：科学家们正在探讨的三个问题。
Nature. 2020 Sep;585(7824):168-169. doi: 10.1038/d41586-020-02506-y.
6
Is Herd Immunity Against SARS-CoV-2 a Silver Lining?针对新冠病毒的群体免疫是一线希望吗？
Front Immunol. 2020 Sep 30;11:586781. doi: 10.3389/fimmu.2020.586781. eCollection 2020.
7
Advances in skin science enable the development of a COVID-19 vaccine.皮肤科学的进展推动了新冠疫苗的研发。
J Am Acad Dermatol. 2020 Oct;83(4):1226-1227. doi: 10.1016/j.jaad.2020.05.126. Epub 2020 May 30.
8
COVID-19 therapies and vaccine landscape.新冠病毒病（COVID-19）的治疗方法与疫苗情况
Nat Mater. 2020 Aug;19(8):809. doi: 10.1038/s41563-020-0758-9.
9
Developing Covid-19 Vaccines at Pandemic Speed.以大流行速度研发新冠疫苗。
N Engl J Med. 2020 May 21;382(21):1969-1973. doi: 10.1056/NEJMp2005630. Epub 2020 Mar 30.
10
Potential Challenges for Coronavirus (SARS-CoV-2) Vaccines Under Trial.正在试验的新型冠状病毒（SARS-CoV-2）疫苗面临的潜在挑战。
Front Immunol. 2020 Sep 29;11:561851. doi: 10.3389/fimmu.2020.561851. eCollection 2020.
引用本文的文献
1
An Evaluation of the Cellular and Humoral Response of a Multi-Epitope Vaccine Candidate Against COVID-19 with Different Alum Adjuvants.一种针对COVID-19的多表位候选疫苗与不同铝佐剂的细胞和体液反应评估。
Pathogens. 2024 Dec 9;13(12):1081. doi: 10.3390/pathogens13121081.
2
COVID-19: Recent Insight in Genomic Feature, Pathogenesis, Immunological Biomarkers, Treatment Options and Clinical Updates on SARS-CoV-2.新型冠状病毒肺炎：关于严重急性呼吸综合征冠状病毒2的基因组特征、发病机制、免疫生物标志物、治疗选择及临床进展的最新见解
Curr Genomics. 2024 Apr 8;25(2):69-87. doi: 10.2174/0113892029291098240129113500.
3
Ginseng Polysaccharide Enhances the Humoral and Cellular Immune Responses to SARS-CoV-2 RBD Protein Subunit Vaccines.人参多糖增强对SARS-CoV-2 RBD蛋白亚单位疫苗的体液免疫和细胞免疫反应。
Vaccines (Basel). 2023 Dec 8;11(12):1833. doi: 10.3390/vaccines11121833.
4
Human in vitro modeling of adjuvant formulations demonstrates enhancement of immune responses to SARS-CoV-2 antigen.佐剂配方的人体体外模型显示对SARS-CoV-2抗原的免疫反应增强。
NPJ Vaccines. 2023 Oct 26;8(1):163. doi: 10.1038/s41541-023-00759-y.
5
Monovalent Omicron COVID-19 vaccine triggers superior neutralizing antibody responses against Omicron subvariants than Delta and Omicron bivalent vaccine.单价奥密克戎 COVID-19 疫苗引发的针对奥密克戎亚变体的中和抗体反应优于针对德尔塔和奥密克戎双价疫苗的反应。
Hum Vaccin Immunother. 2023 Aug;19(2):2264589. doi: 10.1080/21645515.2023.2264589. Epub 2023 Oct 17.
6
Characterizing the cellular and molecular variabilities of peripheral immune cells in healthy recipients of BBIBP-CorV inactivated SARS-CoV-2 vaccine by single-cell RNA sequencing.通过单细胞 RNA 测序描绘健康接种 BBIBP-CorV 灭活 SARS-CoV-2 疫苗者外周免疫细胞的细胞和分子变异性。
Emerg Microbes Infect. 2023 Dec;12(1):e2187245. doi: 10.1080/22221751.2023.2187245.
7
Investigating the Prevalence of Contact Dermatitis and its Related Factors Among Hospital Staff During the Outbreak of the COVID-19 Epidemic: A Cross-Sectional Study.调查新冠疫情爆发期间医院工作人员接触性皮炎的患病率及其相关因素：一项横断面研究。
Iran J Nurs Midwifery Res. 2022 May 23;27(3):236-242. doi: 10.4103/ijnmr.IJNMR_373_20. eCollection 2022 May-Jun.
8
Designing multi-epitope based peptide vaccine targeting spike protein SARS-CoV-2 B1.1.529 (Omicron) variant using computational approaches.利用计算方法设计靶向严重急性呼吸综合征冠状病毒2（SARS-CoV-2）B1.1.529（奥密克戎）变体刺突蛋白的多表位肽疫苗。
Struct Chem. 2022;33(6):2243-2260. doi: 10.1007/s11224-022-02027-6. Epub 2022 Sep 20.
9
Small GTPase-A Key Role in Host Cell for Coronavirus Infection and a Potential Target for Coronavirus Vaccine Adjuvant Discovery.小 GTPase-A 在冠状病毒感染宿主细胞中的关键作用及其作为冠状病毒疫苗佐剂发现的潜在靶点。
Viruses. 2022 Sep 14;14(9):2044. doi: 10.3390/v14092044.
10
Recent advances in the vaccine development for the prophylaxis of SARS Covid-19.SARS-CoV-19 疫苗预防的最新进展。
Int Immunopharmacol. 2022 Oct;111:109175. doi: 10.1016/j.intimp.2022.109175. Epub 2022 Aug 17.
本文引用的文献
1
No credible evidence supporting claims of the laboratory engineering of SARS-CoV-2.没有可信证据支持新冠病毒是通过实验室工程制造的说法。
Emerg Microbes Infect. 2020 Feb 26;9(1):505-507. doi: 10.1080/22221751.2020.1733440. eCollection 2020.
2
Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes.2019-nCoV 感染患者的分子和血清学调查：多种脱落途径的意义。
Emerg Microbes Infect. 2020 Feb 17;9(1):386-389. doi: 10.1080/22221751.2020.1729071. eCollection 2020.
3
Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody.一种严重急性呼吸系统综合征冠状病毒特异性人源单克隆抗体对 2019 新型冠状病毒刺突蛋白的有效结合。
Emerg Microbes Infect. 2020 Feb 17;9(1):382-385. doi: 10.1080/22221751.2020.1729069. eCollection 2020.
4
HIV-1 did not contribute to the 2019-nCoV genome.HIV-1并非2019新型冠状病毒基因组的组成部分。
Emerg Microbes Infect. 2020 Feb 14;9(1):378-381. doi: 10.1080/22221751.2020.1727299. eCollection 2020.
5
RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak.基于 RNA 的宏基因组二代测序（mNGS）方法从 2019 年武汉暴发的两例肺炎个体病例中鉴定出一种新型人类冠状病毒。
Emerg Microbes Infect. 2020 Feb 5;9(1):313-319. doi: 10.1080/22221751.2020.1725399. eCollection 2020.
6
An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies.一种在中国武汉引发肺炎疫情的新型冠状病毒：呼吁制定治疗和预防策略。
Emerg Microbes Infect. 2020 Jan 31;9(1):275-277. doi: 10.1080/22221751.2020.1723441. eCollection 2020.
7
Importation and Human-to-Human Transmission of a Novel Coronavirus in Vietnam.越南新型冠状病毒的输入及人传人情况
N Engl J Med. 2020 Feb 27;382(9):872-874. doi: 10.1056/NEJMc2001272. Epub 2020 Jan 28.
8
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan.从武汉旅行回来后出现非典型肺炎症状的患者身上分离出的 2019 年新型人致病冠状病毒的基因组特征。
Emerg Microbes Infect. 2020 Jan 28;9(1):221-236. doi: 10.1080/22221751.2020.1719902. eCollection 2020.
9
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster.一个涉及 2019 年新型冠状病毒的家庭聚集性肺炎病例，提示存在人际传播：一项家庭聚集性研究。
Lancet. 2020 Feb 15;395(10223):514-523. doi: 10.1016/S0140-6736(20)30154-9. Epub 2020 Jan 24.
10
A Novel Coronavirus from Patients with Pneumonia in China, 2019.2019 年中国肺炎患者中的一种新型冠状病毒。
N Engl J Med. 2020 Feb 20;382(8):727-733. doi: 10.1056/NEJMoa2001017. Epub 2020 Jan 24.
Zotero 插件